Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
- PMID: 35211016
- PMCID: PMC8861529
- DOI: 10.3389/fphar.2022.808440
Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
Abstract
Purpose: The purpose of the study is to evaluate the effects of 0.01% atropine eye drops on accommodative system parameters among teenagers with low myopia. Methods: Ninety-five myopic teenagers [39 boys (8.69 ± 2.473) and 56 girls (8.54 ± 2.054) aged 5-17 years] with no history of eye disease were enrolled. Biometric and accommodative system parameters were evaluated before and at 1 week, 1 month, 3 months, and 6 months of 0.01% atropine eye drop instillation. Results: Participants without accommodative demand at 6 months demonstrated insignificant changes after the atropine instillation (all p > 0.05). Nevertheless, there were significant differences in accommodative sensitivity, accommodative amplitude, accommodative responsiveness, and negative relative accommodation (NRA) at 3 months compared with baseline after atropine instillation (all p < 0.05). Except spherical equivalent refraction, cornea thickness, intraocular pressure, and axial length were stable after the 0.01% atropine instillation (all p > 0.05). Conclusion: Morphologically, current measurements suggested that 0.01% atropine had favorable reduction of accommodation for childhood low myopia over a half-year period.
Keywords: accommodation; axial length; low-concentration atropine; myopia; ocular biometric components; spherical equivalent.
Copyright © 2022 Li, Zhang, Tian, Zhang, Zhang, Zhang, Chen, Qi, Wu, Jiang, Yang, Yang, Liu and Zhang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


References
-
- Azuara-Blanco A., Logan N., Strang N., Saunders K., Allen P. M., Weir R., et al. (2020). Low-dose (0.01%) Atropine Eye-Drops to Reduce Progression of Myopia in Children: a Multicentre Placebo-Controlled Randomised Trial in the UK (CHAMP-UK)-study Protocol. Br. J. Ophthalmol. 104 (7), 950–955. 10.1136/bjophthalmol-2019-314819 - DOI - PubMed
LinkOut - more resources
Full Text Sources